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Background/introduction
Triggered release of drugs from carrier systems in vivo
is widely investigated for targeted tumor therapy. During
the past several years, an ultrasound-sensitive liposome-
microbubble pendant carrier has been developed: micro-
bubbles, decorated with liposomes that carry e.g., doxor-
ubicin, release the drug in response to ultrasound pulse.
However, due to low drug load, those particles were
not successful for tumor therapy in vivo. In this study, we
are able to prepare particles with high doxorubicin load,
and achieve successful inhibition of tumor growth in a
subcutaneous murine tumor model.
Methods
Decafluorobutane microbubbles were stabilized with a
shell consisting of DSPC, PEG stearate and biotin-PEG-
DSPE (20:20:1 mass ratio). Liposomes carrying sodium
citrate were prepared from DOPC, cholesterol and bio-
tin-amidocaproyl-DSPE, Remote loading was used to
entrap doxorubicin in liposomes. Streptavidin linker
bridged biotinylated microbubbles and liposomes, with
pendant complex formation. C57BL/6 mice were
injected subcutaneously with MC38 colon carcinoma
cells (J. Schlom, NIH); therapy has been initiated as
tumors reached 4-5 mm. Doxorubicin-liposome-micro-
bubble complexes were injected intravenously (6 mg/kg
doxorubicin). Contrast ultrasound imaging with Sequoia
512 (nondestructive CPS imaging, 7 MHz, MI 0.2) was
used to monitor the particles in the tumor vasculature.
Therapeutic ultrasound treatment with Birtcher Mega-
son apparatus transducer pointed at the tumor was
initiated immediately after complex injection (0.6 W/
cm2, 1 MHz continuous sine wave applied for 3 s with
10 s interval between ultrasound pulses to ensure
replenishment of drug complexes in the vasculature).
Results and conclusions
Doxorubicin-liposome-microbubble complexes have
been prepared. These pendant particles demonstrated
excellent drug load (>1 pg doxorubicin per complex, an
order of magnitude higher than what was demonstrated
earlier with doxil-like liposomes). Thus, administering
6 mg/kg doxorubicin became feasible, and was per-
formed repeatedly, twice a week for the first two weeks,
and then repeated once a week; ultrasound imaging con-
firmed tumor perfusion with drug carrier. Mice did not
lose body mass due to treatment. In response to doxor-
ubicin particle administration combined with insonation,
significant suppression of tumor growth was achieved, as
compared with control untreated animals (p<0.05); some
of treated tumors have reduced size, while untreated
controls demonstrated accelerating tumor size increase.
Fluorescence microscopy of frozen tumor tissue sections
confirmed doxorubicin deposition. In conclusion, repeated
administration of doxorubicin-liposome-microbubble par-
ticles combined with ultrasound treatment of the tumor
under ultrasound imaging guidance achieved significant
suppression of tumor growth in a subcutaneous murine
tumor model.
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